Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Kiromic Biopharma, Inc. (KRBP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/06/2023 |
4
| BERSANI PIETRO (CEO) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 65,600 restricted stock units
@ $0 |
|
10/06/2023 |
4
| Misajon Pamela (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
10/06/2023 |
4
| NAGEL MICHAEL (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 18,000 restricted stock units
@ $0 |
|
10/06/2023 |
4
| Catlin Michael (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
10/06/2023 |
4
| Hungerford Brian (CFO) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 21,900 restricted stock units
@ $0 |
|
08/15/2022 |
4
| Dahlbeck Scott (Chief of Staff) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 50,000 shares
@ $0 |
|
08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Cicchetti Americo (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 183,600 options to buy
@ $0.43, valued at
$78.9k
|
|
07/05/2022 |
4
| Tirelli Francis X (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 183,600 options to buy
@ $0.43, valued at
$78.9k
|
|
07/05/2022 |
4
| Reeves Karen (Director) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 183,600 options to buy
@ $0.43, valued at
$78.9k
|
|
05/25/2022 |
4
| Dahlbeck Scott (Chief Medical Officer) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Exercised 17,240 restricted stock units
@ $0 |
|
09/10/2021 |
4
| Chiriva Internati Maurizio (CEO) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Bought 2,800 shares
@ $3.699, valued at
$10.4k
|
|
08/02/2021 |
4
| Ryan Michael Charles (See Remarks) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Acquired 50,189 shares
@ $0 Acquired 31,991 restricted stock units
@ $0 |
|
06/24/2021 |
4
| Rotino Gianluca (CHIEF STRAT & INNOV OFFICER) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 71,985 restricted stock units
@ $0 |
|
06/24/2021 |
4
| Nunez Ignacio (CHIEF OPERAT. AND MANUF. OFFI.) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 17,710 restricted stock units
@ $0 Granted 147,038 options to buy
@ $8.47, valued at
$1.2M
|
|
05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Rotino Gianluca (See Remarks) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 4,423 options to buy
@ $8.14, valued at
$36k
|
|
01/06/2021 |
4
| Tontat Tony (CFO & COO) has filed a Form 4 on Kiromic Biopharma, Inc.
Txns:
| Granted 5,528 options to buy
@ $8.14, valued at
$45k
|
|
|
|